• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全切片图像的替代生物标志物预测在评估肺腺癌总生存中的应用

Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma.

作者信息

Murchan Pierre, Baird Anne-Marie, Ó Broin Pilib, Sheils Orla, Finn Stephen P

机构信息

Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, D08 W9RT Dublin, Ireland.

The SFI Centre for Research Training in Genomics Data Science, University of Galway, H91 CF50 Galway, Ireland.

出版信息

Diagnostics (Basel). 2024 Feb 20;14(5):462. doi: 10.3390/diagnostics14050462.

DOI:10.3390/diagnostics14050462
PMID:38472935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10930763/
Abstract

BACKGROUND

Recent advances in computational pathology have shown potential in predicting biomarkers from haematoxylin and eosin (H&E) whole-slide images (WSI). However, predicting the outcome directly from WSIs remains a substantial challenge. In this study, we aimed to investigate how gene expression, predicted from WSIs, could be used to evaluate overall survival (OS) in patients with lung adenocarcinoma (LUAD).

METHODS

Differentially expressed genes (DEGs) were identified from The Cancer Genome Atlas (TCGA)-LUAD cohort. Cox regression analysis was performed on DEGs to identify the gene prognostics of OS. Attention-based multiple instance learning (AMIL) models were trained to predict the expression of identified prognostic genes from WSIs using the TCGA-LUAD dataset. Models were externally validated in the Clinical Proteomic Tumour Analysis Consortium (CPTAC)-LUAD dataset. The prognostic value of predicted gene expression values was then compared to the true gene expression measurements.

RESULTS

The expression of 239 prognostic genes could be predicted in TCGA-LUAD with cross-validated Pearson's R > 0.4. Predicted gene expression demonstrated prognostic performance, attaining a cross-validated concordance index of up to 0.615 in TCGA-LUAD through Cox regression. In total, 36 genes had predicted expression in the external validation cohort that was prognostic of OS.

CONCLUSIONS

Gene expression predicted from WSIs is an effective method of evaluating OS in patients with LUAD. These results may open up new avenues of cost- and time-efficient prognosis assessment in LUAD treatment.

摘要

背景

计算病理学的最新进展已显示出从苏木精和伊红(H&E)全切片图像(WSI)预测生物标志物的潜力。然而,直接从WSI预测结果仍然是一项重大挑战。在本研究中,我们旨在探讨如何利用从WSI预测的基因表达来评估肺腺癌(LUAD)患者的总生存期(OS)。

方法

从癌症基因组图谱(TCGA)-LUAD队列中鉴定出差异表达基因(DEG)。对DEG进行Cox回归分析,以确定OS的基因预后指标。使用TCGA-LUAD数据集训练基于注意力的多实例学习(AMIL)模型,以从WSI预测已鉴定的预后基因的表达。在临床蛋白质组肿瘤分析联盟(CPTAC)-LUAD数据集中对模型进行外部验证。然后将预测的基因表达值的预后价值与真实的基因表达测量值进行比较。

结果

在TCGA-LUAD中可以预测239个预后基因的表达,交叉验证的Pearson's R>0.4。预测的基因表达显示出预后性能,通过Cox回归在TCGA-LUAD中获得的交叉验证一致性指数高达0.615。总共有36个基因在外部验证队列中有预测表达,且这些表达对OS具有预后意义。

结论

从WSI预测的基因表达是评估LUAD患者OS的有效方法。这些结果可能为LUAD治疗中经济高效的预后评估开辟新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/49d3e0b59fd8/diagnostics-14-00462-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/44dab0b19d06/diagnostics-14-00462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/a6b657d1a8a4/diagnostics-14-00462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/12187b0e9f38/diagnostics-14-00462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/59179dc8cd02/diagnostics-14-00462-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/49d3e0b59fd8/diagnostics-14-00462-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/44dab0b19d06/diagnostics-14-00462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/a6b657d1a8a4/diagnostics-14-00462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/12187b0e9f38/diagnostics-14-00462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/59179dc8cd02/diagnostics-14-00462-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef41/10930763/49d3e0b59fd8/diagnostics-14-00462-g005.jpg

相似文献

1
Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma.基于全切片图像的替代生物标志物预测在评估肺腺癌总生存中的应用
Diagnostics (Basel). 2024 Feb 20;14(5):462. doi: 10.3390/diagnostics14050462.
2
Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.基于TCGA和GEO数据库鉴定三基因表达特征并构建预测肺腺癌总生存期的预后列线图。
Transl Lung Cancer Res. 2022 Jul;11(7):1479-1496. doi: 10.21037/tlcr-22-444.
3
Lung Cancer Diagnosis on Virtual Histologically Stained Tissue Using Weakly Supervised Learning.基于弱监督学习的虚拟组织染色切片肺癌诊断
Mod Pathol. 2024 Jun;37(6):100487. doi: 10.1016/j.modpat.2024.100487. Epub 2024 Apr 7.
4
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.TOP2A 和 UBE2C 表达升高与手术切除的肺腺癌患者预后不良相关:基于免疫组织化学分析和生物信息学的研究。
J Cancer Res Clin Oncol. 2020 Apr;146(4):821-841. doi: 10.1007/s00432-020-03147-4. Epub 2020 Feb 26.
5
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.基于代谢相关基因的肺腺癌预后标志物的建立与验证
Cancer Cell Int. 2021 Apr 15;21(1):219. doi: 10.1186/s12935-021-01915-x.
6
Tumor microenvironment related novel signature predict lung adenocarcinoma survival.肿瘤微环境相关的新型标志物可预测肺腺癌的生存期。
PeerJ. 2021 Jan 14;9:e10628. doi: 10.7717/peerj.10628. eCollection 2021.
7
Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.用于预测肺腺癌总生存期的铁死亡相关基因特征的开发与验证
Front Cell Dev Biol. 2021 Jul 7;9:684259. doi: 10.3389/fcell.2021.684259. eCollection 2021.
8
Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.早期肺腺癌中一种稳健的免疫相关预后标志物的开发与验证
J Transl Med. 2020 Oct 7;18(1):380. doi: 10.1186/s12967-020-02545-z.
9
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).一种七基因预后特征可预测肺腺癌(LUAD)患者的总生存期。
Cancer Cell Int. 2021 Jun 6;21(1):294. doi: 10.1186/s12935-021-01975-z.
10
A novel transcriptomic signature associated with lymphovascular invasion predicts clinical outcomes, tumor microenvironment, and therapeutic response in lung adenocarcinoma.一种与淋巴管侵犯相关的新型转录组特征可预测肺腺癌的临床结局、肿瘤微环境及治疗反应。
Int Immunopharmacol. 2024 Jan 25;127:111286. doi: 10.1016/j.intimp.2023.111286. Epub 2023 Dec 7.

本文引用的文献

1
Regression-based Deep-Learning predicts molecular biomarkers from pathology slides.基于回归的深度学习从病理切片中预测分子生物标志物。
Nat Commun. 2024 Feb 10;15(1):1253. doi: 10.1038/s41467-024-45589-1.
2
A Deep Learning Approach for Prognostic Evaluation of Lung Adenocarcinoma Based on Cuproptosis-Related Genes.一种基于铜死亡相关基因的肺腺癌预后评估的深度学习方法。
Biomedicines. 2023 May 19;11(5):1479. doi: 10.3390/biomedicines11051479.
3
Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study.
基于自监督深度学习的癌症病理切片的可泛化生物标志物预测:一项回顾性多中心研究。
Cell Rep Med. 2023 Apr 18;4(4):100980. doi: 10.1016/j.xcrm.2023.100980. Epub 2023 Mar 22.
4
Learning to predict RNA sequence expressions from whole slide images with applications for search and classification.从全切片图像中预测 RNA 序列表达并应用于搜索和分类。
Commun Biol. 2023 Mar 22;6(1):304. doi: 10.1038/s42003-023-04583-x.
5
The Gene Ontology knowledgebase in 2023.2023 版基因本体论知识库。
Genetics. 2023 May 4;224(1). doi: 10.1093/genetics/iyad031.
6
A multicenter-retrospective cohort study of chromosome instability in lung cancer: clinical characteristics and prognosis of patients harboring chromosomal instability detected by metagenomic next-generation sequencing.一项关于肺癌染色体不稳定性的多中心回顾性队列研究:通过宏基因组二代测序检测到染色体不稳定的患者的临床特征和预后
J Thorac Dis. 2023 Jan 31;15(1):112-122. doi: 10.21037/jtd-22-1732. Epub 2023 Jan 15.
7
Artificial intelligence for multimodal data integration in oncology.人工智能在肿瘤学中用于多模态数据整合。
Cancer Cell. 2022 Oct 10;40(10):1095-1110. doi: 10.1016/j.ccell.2022.09.012.
8
Development and validation of a TRP-related gene signature for overall survival prediction in lung adenocarcinoma.用于预测肺腺癌总生存期的TRP相关基因特征的开发与验证
Front Genet. 2022 Sep 15;13:905650. doi: 10.3389/fgene.2022.905650. eCollection 2022.
9
Facts and Hopes on the Use of Artificial Intelligence for Predictive Immunotherapy Biomarkers in Cancer.人工智能在癌症预测性免疫治疗生物标志物中的应用的事实和展望。
Clin Cancer Res. 2023 Jan 17;29(2):316-323. doi: 10.1158/1078-0432.CCR-22-0390.
10
Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.基于TCGA和GEO数据库鉴定三基因表达特征并构建预测肺腺癌总生存期的预后列线图。
Transl Lung Cancer Res. 2022 Jul;11(7):1479-1496. doi: 10.21037/tlcr-22-444.